Pre-clinical activity of PR-104 as monotherapy and in combination with sorafenib in hepatocellular carcinoma

ResearchSpace/Manakin Repository

Full text options

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Advanced Search

Browse